Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)

The requested reference [b2e8a13c5192bf39bce6b6408cfd5bd4c745689b] no longer exists in our database. It has been replaced by the current reference: [f20c943a1a9525e76ee0572019a8fa38f4890e7a]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to determine whether Endostar with Gemcitabine-Carboplatin are more effective than Gemcitabine-Carboplatin alone in the treatment of Non-Small Cell Lung Cancer (NSCLC),and about Endostar ,Compared with intravenous, Continued vein-pumping maby is a more effective way.
Epistemonikos ID: c7c19a23851028a4b04e4afd94a7f3b78a45e8ef
First added on: May 10, 2024